Phase-III study of a novel hypoglycemic agent, AY4166, on NIDDM patients in Japan (2) : Placebo-controlled multicenter double-bind study

Journal

• Clin Pharmacol Ther

  Clin Pharmacol Ther 7 729-754, 1997